한글목차

세계의 프로포폴약 시장 규모는 2024년에 14억 달러로 추정되며, 2025-2031년의 예측 기간 중 CAGR 3.6%로 성장하며, 2031년까지 17억 6,400만 달러로 확대할 것으로 예측되고 있습니다.

이 보고서는 최근 프로포폴 의약품에 대한 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업적 발자취, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구축 등의 관점에서 종합적인 평가를 제공합니다.

2024년 세계 프로포폴 의약품 생산량은 약 3억 7,600만 단위, 세계 평균 시장 가격은 단위당 약 3.7달러에 달했습니다. 프로포폴은 전신마취의 도입 및 유지, 인공호흡기를 착용한 성인 환자의 진정 및 시술시 진정에 사용되는 단시간 작용하는 정맥 마취제입니다. 프로포폴은 빠른 마취 시작, 빠른 각성, 완벽한 기능 회복, 수술 후 메스꺼움, 구토 등의 부작용 발생률이 낮다는 장점이 있습니다.

수요 증가:

만성질환, 수술, 의료 시술이 증가함에 따라 프로포폴에 대한 수요가 확대되고 있습니다. 고령화, 라이프스타일의 변화, 신흥 시장의 헬스케어 인프라 확충도 프로포폴 수요 증가의 한 요인으로 작용하고 있습니다.

기술적 진보:

약물전달 시스템 및 모니터링 기술의 발전으로 프로포폴의 사용이 확대되고 있습니다. 목표 농도 제어 주입(TCI) 시스템 등의 혁신 기술로 보다 정밀한 투여가 가능해져 안전성과 유효성이 향상되고 있습니다.

적용 범위 확대:

프로포폴의 적용 범위는 기존의 수술 및 진단 절차 외에도 소아 마취, 수의학, 난치성 우울증과 같은 특정 정신 질환의 치료에 대한 적응증 외 사용으로 확대되고 있습니다.

경쟁의 심화:

향후 수년간 제조업체 간의 경쟁은 더욱 치열해질 것으로 예측됩니다. 또한 프로포폴 대체품이 더 많은 시장 점유율을 확보하려는 움직임도 예상됩니다.

이 보고서는 세계 프로포폴 의약품 시장에 대해 총판매량, 판매 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

이 보고서는 2024년을 기준 연도, 2020-2031년의 과거 데이터와 예측 데이터를 포함하여 판매량(백만 단위) 및 매출액(백만 달러)으로 프로포폴약품 시장 규모, 추정 및 예측을 제시합니다. 정량적, 정성적 분석을 통해 독자들이 프로포폴 의약품 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 구도 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 지원합니다.

시장 세분화

기업별

• Fresenius Kabi
• Aspen Pharma
• B. Braun
• Pfizer
• Dr. Reddy's Laboratories
• Rusoma
• Centurion Healthcare
• Wellona Pharma
• NEON
• Flagship Biotech
• Xi'an Libang Pharmaceutical
• Guangdong Jiabo Pharmaceutical
• Sichuan Biokin Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Beijing Sciecure Pharmaceutical
• Jiangsu Nhwa Pharmaceutical
• Jiangsu Yingke Biopharmaceutical

유형별 부문

• 10mL
• 20mL
• 50mL
• 100mL

용도별 부문

• 전신 마취
• 의료 시술 진정
• 인공 호흡
• 기타

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동 및 아프리카

영문목차

The global market for Propofol Drug was estimated to be worth US$ 1400 million in 2024 and is forecast to a readjusted size of US$ 1764 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Propofol Drug cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global propofol drug production reached approximately 376 million units, with an average global market price of around US$ 3.7 per unit. Propofol drug is a short-acting, intravenous anesthetic agent used for the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol has the advantages of fast onset of anesthesia induction, rapid awakening, perfect functional recovery, and low incidence of adverse reactions such as postoperative nausea and vomiting.

Increasing Demand:

The demand for propofol is increasing, driven by the rising incidence of chronic diseases, surgeries, and medical procedures. The aging population, changing lifestyles, and growing healthcare infrastructure in emerging markets are also contributing to the increasing demand for propofol.

Technological Advancements:

Advances in drug delivery systems and monitoring technologies are enhancing the use of propofol. Innovations such as target-controlled infusion (TCI) systems allow for more precise administration, improving safety and efficacy.

Expanding Applications:

Beyond traditional surgical and diagnostic procedures, propofol's applications are expanding into areas such as pediatric anesthesia, veterinary medicine, and even in treating certain psychiatric disorders like refractory depression through off-label use.

Intensified Competition:

Competition among manufacturers will intensify further in the coming years. In addition, propofol substitutes will try to occupy more market share.

This report aims to provide a comprehensive presentation of the global market for Propofol Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Propofol Drug by region & country, by Type, and by Application.

The Propofol Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Propofol Drug.

Market Segmentation

By Company

• Fresenius Kabi
• Aspen Pharma
• B. Braun
• Pfizer
• Dr. Reddy's Laboratories
• Rusoma
• Centurion Healthcare
• Wellona Pharma
• NEON
• Flagship Biotech
• Xi'an Libang Pharmaceutical
• Guangdong Jiabo Pharmaceutical
• Sichuan Biokin Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Beijing Sciecure Pharmaceutical
• Jiangsu Nhwa Pharmaceutical
• Jiangsu Yingke Biopharmaceutical

Segment by Type

• 10 mL
• 20 mL
• 50 mL
• 100 mL

Segment by Application

• General Anesthesia
• Medical Procedures Sedation
• Mechanical Ventilation
• Other

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Propofol Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Propofol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Propofol Drug in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Propofol Drug Product Introduction
• 1.2 Global Propofol Drug Market Size Forecast
  • 1.2.1 Global Propofol Drug Sales Value (2020-2031)
  • 1.2.2 Global Propofol Drug Sales Volume (2020-2031)
  • 1.2.3 Global Propofol Drug Sales Price (2020-2031)
• 1.3 Propofol Drug Market Trends & Drivers
  • 1.3.1 Propofol Drug Industry Trends
  • 1.3.2 Propofol Drug Market Drivers & Opportunity
  • 1.3.3 Propofol Drug Market Challenges
  • 1.3.4 Propofol Drug Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Propofol Drug Players Revenue Ranking (2024)
• 2.2 Global Propofol Drug Revenue by Company (2020-2025)
• 2.3 Global Propofol Drug Players Sales Volume Ranking (2024)
• 2.4 Global Propofol Drug Sales Volume by Company Players (2020-2025)
• 2.5 Global Propofol Drug Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Propofol Drug Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Propofol Drug Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Propofol Drug
• 2.9 Propofol Drug Market Competitive Analysis
  • 2.9.1 Propofol Drug Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Propofol Drug Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Propofol Drug as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 10 mL
  • 3.1.2 20 mL
  • 3.1.3 50 mL
  • 3.1.4 100 mL
• 3.2 Global Propofol Drug Sales Value by Type
  • 3.2.1 Global Propofol Drug Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Propofol Drug Sales Value, by Type (2020-2031)
  • 3.2.3 Global Propofol Drug Sales Value, by Type (%) (2020-2031)
• 3.3 Global Propofol Drug Sales Volume by Type
  • 3.3.1 Global Propofol Drug Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Propofol Drug Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Propofol Drug Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Propofol Drug Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 General Anesthesia
  • 4.1.2 Medical Procedures Sedation
  • 4.1.3 Mechanical Ventilation
  • 4.1.4 Other
• 4.2 Global Propofol Drug Sales Value by Application
  • 4.2.1 Global Propofol Drug Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Propofol Drug Sales Value, by Application (2020-2031)
  • 4.2.3 Global Propofol Drug Sales Value, by Application (%) (2020-2031)
• 4.3 Global Propofol Drug Sales Volume by Application
  • 4.3.1 Global Propofol Drug Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Propofol Drug Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Propofol Drug Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Propofol Drug Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Propofol Drug Sales Value by Region
  • 5.1.1 Global Propofol Drug Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Propofol Drug Sales Value by Region (2020-2025)
  • 5.1.3 Global Propofol Drug Sales Value by Region (2026-2031)
  • 5.1.4 Global Propofol Drug Sales Value by Region (%), (2020-2031)
• 5.2 Global Propofol Drug Sales Volume by Region
  • 5.2.1 Global Propofol Drug Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Propofol Drug Sales Volume by Region (2020-2025)
  • 5.2.3 Global Propofol Drug Sales Volume by Region (2026-2031)
  • 5.2.4 Global Propofol Drug Sales Volume by Region (%), (2020-2031)
• 5.3 Global Propofol Drug Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Propofol Drug Sales Value, 2020-2031
  • 5.4.2 North America Propofol Drug Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Propofol Drug Sales Value, 2020-2031
  • 5.5.2 Europe Propofol Drug Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Propofol Drug Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Propofol Drug Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Propofol Drug Sales Value, 2020-2031
  • 5.7.2 South America Propofol Drug Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Propofol Drug Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Propofol Drug Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Propofol Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Propofol Drug Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Propofol Drug Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Propofol Drug Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Propofol Drug Sales Value, 2020-2031
  • 6.3.2 United States Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Propofol Drug Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Propofol Drug Sales Value, 2020-2031
  • 6.4.2 Europe Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Propofol Drug Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Propofol Drug Sales Value, 2020-2031
  • 6.5.2 China Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Propofol Drug Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Propofol Drug Sales Value, 2020-2031
  • 6.6.2 Japan Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Propofol Drug Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Propofol Drug Sales Value, 2020-2031
  • 6.7.2 South Korea Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Propofol Drug Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Propofol Drug Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Propofol Drug Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Propofol Drug Sales Value, 2020-2031
  • 6.9.2 India Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Propofol Drug Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Fresenius Kabi
  • 7.1.1 Fresenius Kabi Company Information
  • 7.1.2 Fresenius Kabi Introduction and Business Overview
  • 7.1.3 Fresenius Kabi Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Fresenius Kabi Propofol Drug Product Offerings
  • 7.1.5 Fresenius Kabi Recent Development
• 7.2 Aspen Pharma
  • 7.2.1 Aspen Pharma Company Information
  • 7.2.2 Aspen Pharma Introduction and Business Overview
  • 7.2.3 Aspen Pharma Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Aspen Pharma Propofol Drug Product Offerings
  • 7.2.5 Aspen Pharma Recent Development
• 7.3 B. Braun
  • 7.3.1 B. Braun Company Information
  • 7.3.2 B. Braun Introduction and Business Overview
  • 7.3.3 B. Braun Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 B. Braun Propofol Drug Product Offerings
  • 7.3.5 B. Braun Recent Development
• 7.4 Pfizer
  • 7.4.1 Pfizer Company Information
  • 7.4.2 Pfizer Introduction and Business Overview
  • 7.4.3 Pfizer Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Pfizer Propofol Drug Product Offerings
  • 7.4.5 Pfizer Recent Development
• 7.5 Dr. Reddy's Laboratories
  • 7.5.1 Dr. Reddy's Laboratories Company Information
  • 7.5.2 Dr. Reddy's Laboratories Introduction and Business Overview
  • 7.5.3 Dr. Reddy's Laboratories Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Dr. Reddy's Laboratories Propofol Drug Product Offerings
  • 7.5.5 Dr. Reddy's Laboratories Recent Development
• 7.6 Rusoma
  • 7.6.1 Rusoma Company Information
  • 7.6.2 Rusoma Introduction and Business Overview
  • 7.6.3 Rusoma Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Rusoma Propofol Drug Product Offerings
  • 7.6.5 Rusoma Recent Development
• 7.7 Centurion Healthcare
  • 7.7.1 Centurion Healthcare Company Information
  • 7.7.2 Centurion Healthcare Introduction and Business Overview
  • 7.7.3 Centurion Healthcare Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Centurion Healthcare Propofol Drug Product Offerings
  • 7.7.5 Centurion Healthcare Recent Development
• 7.8 Wellona Pharma
  • 7.8.1 Wellona Pharma Company Information
  • 7.8.2 Wellona Pharma Introduction and Business Overview
  • 7.8.3 Wellona Pharma Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Wellona Pharma Propofol Drug Product Offerings
  • 7.8.5 Wellona Pharma Recent Development
• 7.9 NEON
  • 7.9.1 NEON Company Information
  • 7.9.2 NEON Introduction and Business Overview
  • 7.9.3 NEON Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 NEON Propofol Drug Product Offerings
  • 7.9.5 NEON Recent Development
• 7.10 Flagship Biotech
  • 7.10.1 Flagship Biotech Company Information
  • 7.10.2 Flagship Biotech Introduction and Business Overview
  • 7.10.3 Flagship Biotech Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Flagship Biotech Propofol Drug Product Offerings
  • 7.10.5 Flagship Biotech Recent Development
• 7.11 Xi'an Libang Pharmaceutical
  • 7.11.1 Xi'an Libang Pharmaceutical Company Information
  • 7.11.2 Xi'an Libang Pharmaceutical Introduction and Business Overview
  • 7.11.3 Xi'an Libang Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Xi'an Libang Pharmaceutical Propofol Drug Product Offerings
  • 7.11.5 Xi'an Libang Pharmaceutical Recent Development
• 7.12 Guangdong Jiabo Pharmaceutical
  • 7.12.1 Guangdong Jiabo Pharmaceutical Company Information
  • 7.12.2 Guangdong Jiabo Pharmaceutical Introduction and Business Overview
  • 7.12.3 Guangdong Jiabo Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Guangdong Jiabo Pharmaceutical Propofol Drug Product Offerings
  • 7.12.5 Guangdong Jiabo Pharmaceutical Recent Development
• 7.13 Sichuan Biokin Pharmaceutical
  • 7.13.1 Sichuan Biokin Pharmaceutical Company Information
  • 7.13.2 Sichuan Biokin Pharmaceutical Introduction and Business Overview
  • 7.13.3 Sichuan Biokin Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Sichuan Biokin Pharmaceutical Propofol Drug Product Offerings
  • 7.13.5 Sichuan Biokin Pharmaceutical Recent Development
• 7.14 Sichuan Kelun Pharmaceutical
  • 7.14.1 Sichuan Kelun Pharmaceutical Company Information
  • 7.14.2 Sichuan Kelun Pharmaceutical Introduction and Business Overview
  • 7.14.3 Sichuan Kelun Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Sichuan Kelun Pharmaceutical Propofol Drug Product Offerings
  • 7.14.5 Sichuan Kelun Pharmaceutical Recent Development
• 7.15 Beijing Sciecure Pharmaceutical
  • 7.15.1 Beijing Sciecure Pharmaceutical Company Information
  • 7.15.2 Beijing Sciecure Pharmaceutical Introduction and Business Overview
  • 7.15.3 Beijing Sciecure Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Beijing Sciecure Pharmaceutical Propofol Drug Product Offerings
  • 7.15.5 Beijing Sciecure Pharmaceutical Recent Development
• 7.16 Jiangsu Nhwa Pharmaceutical
  • 7.16.1 Jiangsu Nhwa Pharmaceutical Company Information
  • 7.16.2 Jiangsu Nhwa Pharmaceutical Introduction and Business Overview
  • 7.16.3 Jiangsu Nhwa Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Jiangsu Nhwa Pharmaceutical Propofol Drug Product Offerings
  • 7.16.5 Jiangsu Nhwa Pharmaceutical Recent Development
• 7.17 Jiangsu Yingke Biopharmaceutical
  • 7.17.1 Jiangsu Yingke Biopharmaceutical Company Information
  • 7.17.2 Jiangsu Yingke Biopharmaceutical Introduction and Business Overview
  • 7.17.3 Jiangsu Yingke Biopharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Jiangsu Yingke Biopharmaceutical Propofol Drug Product Offerings
  • 7.17.5 Jiangsu Yingke Biopharmaceutical Recent Development

8 Industry Chain Analysis

• 8.1 Propofol Drug Industrial Chain
• 8.2 Propofol Drug Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Propofol Drug Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Propofol Drug Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer